Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2009 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Partners With IDIS For Ceplene® Named Patient/Compassionate Use Program

EpiCept Partners With IDIS For Ceplene® Named Patient/Compassionate Use Program Partnership Expands Access to Drug in Most Key Markets TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation...
May 29, 2009 00:24 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Webcast of Annual Meeting of Stockholders

EpiCept Announces Webcast of Annual Meeting of Stockholders TARRYTOWN,N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that its annual meeting of...
May 28, 2009 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Presentation of New Crinobulin Data at 2009 American Society of Clinical Oncology Annual Meeting

EpiCept Announces Presentation of New Crinobulin Data at 2009 American Society of Clinical Oncology Annual Meeting TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX...
May 07, 2009 00:03 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Reports First Quarter 2009 Operating and Financial Results

EpiCept Corporation Reports First Quarter 2009 Operating and Financial Results TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating...
May 01, 2009 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report First Quarter 2009 Operating and Financial Results on May 7, 2009

EpiCept to Report First Quarter 2009 Operating and Financial Results on May 7, 2009 TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced...
April 30, 2009 00:02 ET | Source: Immune Pharmaceuticals Inc

Notice of the Annual Meeting of Stockholders of EpiCept Corporation

Notice of the Annual Meeting of Stockholders of EpiCept Corporation TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: With this notice, stockholders of EpiCept Corporation (Nasdaq and OMX...
April 13, 2009 17:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Appoints Recognized Oncology Expert and Pharmaceutical Industry Leader as New Independent Board Member

EpiCept Appoints Recognized Oncology Expert and Pharmaceutical Industry Leader as New Independent Board Member TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and...
February 27, 2009 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Reports Fourth Quarter and Full Year 2008 Operating and Financial Results

EpiCept Corporation Reports Fourth Quarter and Full Year 2008 Operating and Financial Results TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today...
February 23, 2009 19:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report Fourth Quarter and Full Year 2008 Operating and Financial Results on February 27, 2009

EpiCept to Report Fourth Quarter and Full Year 2008 Operating and Financial Results on February 27, 2009 TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and OMX...
February 23, 2009 17:37 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Debt Repayment

EpiCept Announces Debt Repayment TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that it has repaid the outstanding...